Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients

Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients

Copyright © 2018 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 196(2018) vom: 01. Nov., Seite 85-96
1. Verfasser: Lagos, Carolina (VerfasserIn)
Weitere Verfasser: Carvajal, Patricia, Castro, Isabel, Jara, Daniela, González, Sergio, Aguilera, Sergio, Barrera, María-José, Quest, Andrew F G, Bahamondes, Verónica, Molina, Claudio, Urzúa, Ulises, Hermoso, Marcela A, Leyton, Cecilia, González, María-Julieta
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't 5-hydroxymethylcytosine Global DNA methylation Pro-inflammatory cytokines Sjögren's syndrome TET2 Cytokines DNA-Binding Proteins DNMT3A protein, human mehr... MECP2 protein, human Methyl-CpG-Binding Protein 2 Proto-Oncogene Proteins 1123-95-1 5-Methylcytosine 6R795CQT4H Mixed Function Oxygenases EC 1.- TET1 protein, human TET3 protein, human Dioxygenases EC 1.13.11.- TET2 protein, human DNA (Cytosine-5-)-Methyltransferase 1 EC 2.1.1.37 DNA (Cytosine-5-)-Methyltransferases DNA Methyltransferase 3A DNMT1 protein, human Cytidine Deaminase EC 3.5.4.5
LEADER 01000caa a22002652 4500
001 NLM285391674
003 DE-627
005 20231227125823.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2018.06.002  |2 doi 
028 5 2 |a pubmed24n1224.xml 
035 |a (DE-627)NLM285391674 
035 |a (NLM)29894742 
035 |a (PII)S1521-6616(18)30348-6 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Lagos, Carolina  |e verfasserin  |4 aut 
245 1 0 |a Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 14.10.2019 
500 |a Date Revised 13.12.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2018 Elsevier Inc. All rights reserved. 
520 |a Here, we determined the 5-hydroxymethylcytosine (5hmC), 5-methylcytosine (5mC), Ten Eleven Translocation (TETs), and DNA methyltransferases (DNMTs) levels in epithelial and inflammatory cells of labial salivary glands (LSG) from Sjögren's syndrome (SS)-patients and the effect of cytokines on HSG cells. LSG from SS-patients, controls and HSG cells incubated with cytokines were analysed. Levels of 5mC, 5hmC, DNMTs, TET2 and MeCP2 were assessed by immunofluorescence. In epithelial cells from SS-patients, an increase in TET2, 5hmC and a decrease in 5mC and MeCP2 were observed, additionally, high levels of 5mC and DNMTs and low levels of 5hmC were detected in inflammatory cells. Cytokines increased TET2 and 5hmC and decreased 5mC levels. Considering that the TET2 gene.promoter contains response elements for transcription factors activated by cytokines, together to in vitro results suggest that changes in DNA hydroxymethylation, resulting from altered levels of TET2 are likely to be relevant in the Sjögren's syndrome etiopathogenesis 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a 5-hydroxymethylcytosine 
650 4 |a Global DNA methylation 
650 4 |a Pro-inflammatory cytokines 
650 4 |a Sjögren's syndrome 
650 4 |a TET2 
650 7 |a Cytokines  |2 NLM 
650 7 |a DNA-Binding Proteins  |2 NLM 
650 7 |a DNMT3A protein, human  |2 NLM 
650 7 |a MECP2 protein, human  |2 NLM 
650 7 |a Methyl-CpG-Binding Protein 2  |2 NLM 
650 7 |a Proto-Oncogene Proteins  |2 NLM 
650 7 |a 5-hydroxymethylcytosine  |2 NLM 
650 7 |a 1123-95-1  |2 NLM 
650 7 |a 5-Methylcytosine  |2 NLM 
650 7 |a 6R795CQT4H  |2 NLM 
650 7 |a Mixed Function Oxygenases  |2 NLM 
650 7 |a EC 1.-  |2 NLM 
650 7 |a TET1 protein, human  |2 NLM 
650 7 |a EC 1.-  |2 NLM 
650 7 |a TET3 protein, human  |2 NLM 
650 7 |a EC 1.-  |2 NLM 
650 7 |a Dioxygenases  |2 NLM 
650 7 |a EC 1.13.11.-  |2 NLM 
650 7 |a TET2 protein, human  |2 NLM 
650 7 |a EC 1.13.11.-  |2 NLM 
650 7 |a DNA (Cytosine-5-)-Methyltransferase 1  |2 NLM 
650 7 |a EC 2.1.1.37  |2 NLM 
650 7 |a DNA (Cytosine-5-)-Methyltransferases  |2 NLM 
650 7 |a EC 2.1.1.37  |2 NLM 
650 7 |a DNA Methyltransferase 3A  |2 NLM 
650 7 |a EC 2.1.1.37  |2 NLM 
650 7 |a DNMT1 protein, human  |2 NLM 
650 7 |a EC 2.1.1.37  |2 NLM 
650 7 |a Cytidine Deaminase  |2 NLM 
650 7 |a EC 3.5.4.5  |2 NLM 
700 1 |a Carvajal, Patricia  |e verfasserin  |4 aut 
700 1 |a Castro, Isabel  |e verfasserin  |4 aut 
700 1 |a Jara, Daniela  |e verfasserin  |4 aut 
700 1 |a González, Sergio  |e verfasserin  |4 aut 
700 1 |a Aguilera, Sergio  |e verfasserin  |4 aut 
700 1 |a Barrera, María-José  |e verfasserin  |4 aut 
700 1 |a Quest, Andrew F G  |e verfasserin  |4 aut 
700 1 |a Bahamondes, Verónica  |e verfasserin  |4 aut 
700 1 |a Molina, Claudio  |e verfasserin  |4 aut 
700 1 |a Urzúa, Ulises  |e verfasserin  |4 aut 
700 1 |a Hermoso, Marcela A  |e verfasserin  |4 aut 
700 1 |a Leyton, Cecilia  |e verfasserin  |4 aut 
700 1 |a González, María-Julieta  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 196(2018) vom: 01. Nov., Seite 85-96  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:196  |g year:2018  |g day:01  |g month:11  |g pages:85-96 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2018.06.002  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 196  |j 2018  |b 01  |c 11  |h 85-96